SKERI hosted a group of trainees from the University of Michigan Kinesiology program. The visit was organized by Dr. Haylie Miller, an Assistant Professor in the Department of Kinesiology at the University of Michigan, and funded by a generous donation by a UM Kinesiology alum.

A recent publication from the Eye-Head Movement lab was spotlighted by the Psychonomic Society as Featured Content

SKERI's Senior Scientist, Dr. Preeti Verghese - in collaboration with Drs Suzanne McKee of Smith-Kettlewell and Dr. Dennis Levi of Berkeley's Herbert Wertheim School of Optometry & Vision Science - was awarded a 5-year NIH Research Project Grant (R01) from the National Eye Institute to study the potential for residual stereopsis in those with strabismus and amblyopia.

SKERI Associate Scientist Natela Shanidze co-organized the Satellite Meeting of the Society for the Neural Control of Movement (NCM) 2022 Annual Meeting in Dublin, Ireland. The meeting, titled A fine balance: The neural control of eye and head movements in health versus disease, celebrated the scientific contributions of Dr. W. Michael King.

Dr. Catherine Agathos, a Postdoctoral Fellow in the Eye/Head Movement Lab won a Best Poster Award in Basic Science for Postdoctoral Fellow from the International Society of Posture & Gait Research at the 2022 World Congress in Montreal, Canada.

SKERI undergraduate intern Kyra Deams took second place for her poster "Gait-Specific Attentional Profile, Anxiety, and Space Perception in Younger Adults" at the Southeastern Medical Scientist Symposium (SEMSS), hosted virtually by the Vanderbilt University School of Medicine.

Researchers at the SEELAB and collaborators at Alder Hey Children’s Hospital have validated the Higher Visual Function Question Inventory (HVFQI) an assessment tool for vision difficulties in everyday life in children with Cerebral Visual Impairment (CVI) and identified 11 of the fifty-one questions (the Top-11) that were highly sensitive in detecting these visual difficulties

We are saddened to learn of the passing of Alan Scott MD, world-famous ophthalmological researcher who spent much of his career at Smith-Kettlewell including serving for many years as its Co-Director and Director. He is most well-known for his pioneering research into the use of botulinum toxin to modify the characteristics of eye muscles, as a non-invasive alternative to surgery in the treatment of strabismus or crossed eyes.

A Smith-Kettlewell study measuring object information available via echolocation was recognized with a Best Poster award at the 2021 Conference on Object Perception, visual Attention, and visual Memory (OPAM 29).

This collaborative proposal will study the effects of noise exposure on balance and age-related fall risk.